Sun Pharma, Glenmark recall products in US due to manufacturing issues
25 Jul 2022 //
ET HEALTH
Enforcement Report - Week of July 20, 2022
20 Jul 2022 //
FDA
Enforcement Report - Week of July 13, 2022
13 Jul 2022 //
FDA
Enforcement Report - Week of June 29, 2022
29 Jun 2022 //
FDA
Enforcement Report - Week of April 6, 2022
06 Apr 2022 //
FDA
Enforcement Report - Week of October 6, 2021
06 Oct 2021 //
FDA
Enforcement Report - Week of July 17, 2019
17 Jul 2019 //
FDA
Enforcement Report - Week of June 19, 2019
19 Jun 2019 //
FDA
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
Dr Reddy`s Laboratories, Cipla arm recall drugs from American market
29 Apr 2019 //
BUSINESS-STANDARD
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA
Enforcement Report - Week of January 9, 2019
09 Jan 2019 //
FDA
Hybrid Pharma Receives FDA Warning Letter
12 Dec 2018 //
FDA
Enforcement Report - Week of November 7, 2018
07 Nov 2018 //
FDA
New Vitalis Pharmacy (Sterile Drugs Producer) Receives FDA Form 483
03 Oct 2018 //
FDA
Enforcement Report - Week of September 5, 2018
05 Sep 2018 //
FDA
Sun Pharma recalls over 5.2k units of testosterone cypionate injections from US
07 Aug 2018 //
ECONOMIC TIMES
Enforcement Report - Week of August 1, 2018
01 Aug 2018 //
FDA
Cipla’s Generic Testosterone Cypionate Receives Approval In US
25 Jun 2018 //
FDA
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Ferring announces positive outcome of European DCP for Testavan®
16 Mar 2018 //
PRESS RELEASE
Enforcement Report - Week of August 9, 2017
09 Aug 2017 //
FDA
Luitpold Pharm’s Generic Testosterone Cypionate Receives Approval In US
20 Jun 2017 //
FDA
Enforcement Report - Week of May 3, 2017
03 May 2017 //
FDA
Enforcement Report - Week of March 29, 2017
29 Mar 2017 //
FDA
Pacific recalls Testosterone Cypionate due to Lack of Assurance of Sterility
18 Nov 2015 //
FDA
Stroheckers Inc Pharmacy initiates Class I recall of Testosterone Cypionate
16 May 2015 //
FDA